Recurrent Lelliottia amnigena Septic Arthritis in an Immunocompetent Child.
- 1Department of Pediatrics, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, USA.
- 2Department of Pediatric Infectious Diseases, Ryan White Center for Pediatric Infectious Diseases and Global Health, Indianapolis, USA.
Abstract
Human infections secondary to Lelliottia amnigena are rare and have been reported almost exclusively in immunocompromised hosts or following penetrating trauma. We present the case of a previously healthy four-year-old girl who developed left knee septic arthritis caused by L. amnigena without a history of penetrating trauma. Her diagnosis was delayed by initially negative synovial fluid cultures, inconsistent organism nomenclature between laboratories, and a weakly positive Borrelia burgdorferi enzyme-linked immunosorbent assay (ELISA) that broadened the differential. Her symptoms resolved at the completion of her first treatment course. Approximately 18 months later, she re-presented with recurrent left knee infection due to L. amnigena. She was treated with surgical drainage followed by a three-month course of trimethoprim/sulfamethoxazole with complete resolution. This case highlights an unusual pathogen in pediatric septic arthritis and underscores the importance of considering extended or tailored antimicrobial therapy when managing rare organisms with poorly characterized virulence and relapse potential.
Related
- Melioidosis Presenting as a Solitary Liver Abscess With Culture-Negative Septic Arthritis: A Case Report
- Clinical and Microbiological Characteristics of Septic Arthritis in 25 Adults at a Tertiary Hospital in Cambodia: A Single-Center Retrospective Case Series
- Group A Streptococcal Septic Arthritis and Osteomyelitis Presenting As Acute Rheumatic Fever: A Diagnostic Dilemma
- State-of-the-Art Review: Native Joint Septic Arthritis Epidemiology, Pathogenesis, Microbiology, Diagnosis, Management, and Outcomes.
- Septic Arthritis Complicating Growth Plate Integrity in Pediatric Cerebral Palsy: A Rare Presentation.
BibTeX
@article{kooistra2026recurrent,
title = {{Recurrent Lelliottia amnigena Septic Arthritis in an Immunocompetent Child.}},
author = {Jesse Kooistra and Matthew Eisenhardt and John C Christenson and Jonathan A Mayhew},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116790},
url = {https://europepmc.org/article/MED/42920996},
note = {CC BY},
}
RIS
TY - JOUR
TI - Recurrent Lelliottia amnigena Septic Arthritis in an Immunocompetent Child.
AU - Jesse Kooistra
AU - Matthew Eisenhardt
AU - John C Christenson
AU - Jonathan A Mayhew
PY - 2026
DA - 2026/09/23
JO - Cureus
DO - 10.7759/cureus.116790
UR - https://europepmc.org/article/MED/42920996
AB - Human infections secondary to Lelliottia amnigena are rare and have been reported almost exclusively in immunocompromised hosts or following penetrating trauma. We present the case of a previously healthy four-year-old girl who developed left knee septic arthritis caused by L. amnigena without a history of penetrating trauma. Her diagnosis was delayed by initially negative synovial fluid cultures, inconsistent organism nomenclature between laboratories, and a weakly positive Borrelia burgdorferi enzyme-linked immunosorbent assay (ELISA) that broadened the differential. Her symptoms resolved at the completion of her first treatment course. Approximately 18 months later, she re-presented with recurrent left knee infection due to L. amnigena. She was treated with surgical drainage followed by a three-month course of trimethoprim/sulfamethoxazole with complete resolution. This case highlights an unusual pathogen in pediatric septic arthritis and underscores the importance of considering extended or tailored antimicrobial therapy when managing rare organisms with poorly characterized virulence and relapse potential.
SN - 2168-8184
ER -